Strumento inattivo

Altre lingue Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE

Azioni

TRPX

IL0010951403

Prezzo di chiusura TEL AVIV STOCK EXCHANGE Altri mercati azionari
- ^ILS	-

03/06	SciSparc Ltd. si assicura un vantaggio strategico con la concessione di un brevetto europeo	CI
01/04	SciSparc Ltd. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent	03/06
SciSparc Secures Strategic Advantage with Grant of European Patent	31/05
SciSparc to Acquire AutoMax	11/04
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	11/04
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	21/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	14/03
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	14/03
SciSparc : MitoCareX Update - Form 6-K	13/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
Top Premarket Gainers	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07/03
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE

Azioni

TRPX

IL0010951403

Altre lingue

Filtri